World's Best Scientists 2026 revealed!
William U. Shipley

William U. Shipley

D-Index & Metrics

Medicine

D-Index
108
Citations
45110
World Ranking
5982
National Ranking
3197

Overview

William U. Shipley is affiliated with Harvard University in the United States and has a research focus primarily within the field of Medicine. Their publication record spans several subfields including Pulmonary and Respiratory Medicine, Surgery, Urology, Radiation, and Cancer Research.

The main topics of Shipley's work include Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Prostate Cancer Diagnosis and Treatment, Urinary and Genital Oncology Studies, Urological Disorders and Treatments, Advanced Radiotherapy Techniques, and Cancer, Lipids, and Metabolism.

Frequent coauthors collaborating with Shipley are:

  • Jason A. Efstathiou
  • Howard M. Sandler
  • Felix Y. Feng
  • Anthony L. Zietman
  • Thomas M. Pisansky

Shipley's research has been published extensively in several venues, including:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • The Journal of Urology
  • JAMA Oncology
  • European Urology Oncology

Selected recent papers authored or coauthored by Shipley include:

  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis" (2023), published in The Lancet Oncology
  • "Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer" (2021), published in JAMA Oncology
  • "Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer" (2020), published in JAMA Oncology
  • "Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis" (2020), published in Journal of Clinical Oncology
  • "Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials" (2022), published in International Journal of Radiation Oncology*Biology*Physics

Best Publications

  • Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

    Mack Roach;Gerald Hanks;Howard Thames;Paul Schellhammer

  • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate : A randomized controlled trial

    Anthony L. Zietman;Michelle L. DeSilvio;Jerry D. Slater;Carl J. Rossi

  • Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

    Andy Trotti;Roger Byhardt;Joanne Stetz;Clement Gwede

  • Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

    O Dalesio;H van Tinteren;M Clarke;R Peto

  • Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09

    Anthony L. Zietman;Kyounghwa Bae;Jerry D. Slater;William U. Shipley

  • Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon

  • Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

    M V Pilepich;R Caplan;R W Byhardt;C A Lawton

  • Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

    Christopher U. Jones;Daniel Hunt;David G. McGowan;Mahul B. Amin

  • Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

    Eric M. Horwitz;Kyounghwa Bae;Gerald E. Hanks;Arthur Porter

  • Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

    Miljenko V. Pilepich;William T. Sause;William U. Shipley;John M. Krall

  • Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    William U. Shipley;Wendy Seiferheld;Himanshu R. Lukka;Pierre P. Major

  • Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03

    W.U. Shipley;K.A. Winter;D.S. Kaufman;W.R. Lee

  • Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706

    Colleen A. Lawton;Minhee Won;Miljenko V. Pilepich;Sucha O. Asbell

  • Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

    William U. Shipley;Lynn J. Verhey;John E. Munzenrider;Herman D. Suit

  • Biology and Management of Bladder Cancer

    Derek Raghavan;William U. Shipley;Marc B. Garnick;Pamela J. Russell

  • Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    William U. Shipley;Howard D. Thames;Howard M. Sandler;Gerald E. Hanks

  • Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

    Jason A. Efstathiou;Daphna Y. Spiegel;William U. Shipley;Niall M. Heney

  • Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

    Raymond H. Mak;Daniel Hunt;William U. Shipley;Jason A. Efstathiou

  • Radiation dose-volume effects of the urinary bladder.

    Akila N. Viswanathan;Ellen D. Yorke;Lawrence B. Marks;Patricia J. Eifel

  • Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer

    W.U Shipley;D.S Kaufman;E Zehr;N.M Heney

Frequent Co-Authors

Anthony L. Zietman
Anthony L. Zietman Harvard University
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
Gerald E. Hanks
Gerald E. Hanks Fox Chase Cancer Center
Mack Roach
Mack Roach University of California, San Francisco
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Alan Pollack
Alan Pollack University of Miami
Eric M. Horwitz
Eric M. Horwitz Fox Chase Cancer Center
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Those interested in studying Medicine in the USA may also explore related healthcare degrees online for greater flexibility and career advancement. Many top universities now offer cahme accredited online mha programs, helping graduates develop essential management and leadership skills for healthcare settings.

For nurses looking to enhance their qualifications, rn bsn online programs no clinicals allow RNs to earn their Bachelor of Science in Nursing with minimal on-site requirements, making education more accessible.

Those aiming for advanced practice or leadership roles can consider a Doctor of Nursing Practice. Many universities offer dnp online programs that can be completed in less time for motivated students, making it easier to balance education with work. For those seeking a more manageable workload, dnp programs designed for flexibility are also available.

These pathways provide diverse options for advancing your healthcare career without sacrificing your current commitments.

Best Scientists Citing William U. Shipley

Trending Scientists